CD40 expressed on human melanoma cells mediates T cell co-stimulation and tumor cell growth.

CD40 is a 50 kDa molecule, a member of the tumor necrosis factor/nerve growth factor receptor family. It is expressed on B cells, monocytes, dendritic cells and various malignant cells. While the critical relevance of this molecule in T cell-dependent B cell activation is already established, the biological role of CD40-CD154 interaction in non-hematopoietic cells is still unknown. Here we show that CD40 is functionally expressed on human melanoma-derived cell lines. No correlation between surface CD40 expression and the origin of the cell line, primary versus metastatic, was observed. Melanoma cells were shown to be able to co-stimulate TCR-triggered human T cells; moreover, because they do not express CD80 or CD86 co-stimulatory structures, the involvement of additional pathways have to be postulated. We have identified CD40 as one of the molecules involved in melanoma cell-mediated co-stimulation of anti-CD3-triggered human CD4(+) T lymphocytes. In addition, a CD40-dependent pathway, able to enhance tumor cell proliferation at low serum concentrations, in vitro, has been shown to be functional in human melanoma cell lines.

[1]  J. Bonnefoy,et al.  CD40 ligand is functionally expressed on human eosinophils , 1995, European journal of immunology.

[2]  R. Flavell,et al.  Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand , 1995, Nature.

[3]  C. Janeway,et al.  Signals and signs for lymphocyte responses , 1994, Cell.

[4]  Atsushi Hase,et al.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.

[5]  S. Ferrone,et al.  Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens. , 1993, Cancer research.

[6]  R. V. van Lier,et al.  Induction of T cell proliferation with anti‐CD3 switch‐variant monoclonal antibodies: effects of heavy chain isotype in monocyte‐dependent systems , 1987, European journal of immunology.

[7]  I. Stamenkovic,et al.  The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co‐stimulatory activity. , 1992, The EMBO journal.

[8]  R. Flavell,et al.  An essential role for gp39, the ligand for CD40, in thymic selection , 1995, The Journal of experimental medicine.

[9]  J. Banchereau,et al.  CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. , 1997, Journal of immunology.

[10]  P. Hersey,et al.  Expression of the co‐stimulatory molecule CD40 on melanoma cells , 1996 .

[11]  R. V. van Lier,et al.  CD27: marker and mediator of T-cell activation? , 1994, Immunology today.

[12]  S. Fortune,et al.  Ligation of CD40 on fibroblasts induces CD54 (ICAM‐1) and CD106 (VCAM‐1) up‐regulation and IL‐6 production and proliferation , 1995, Journal of leukocyte biology.

[13]  E. Clark,et al.  Molecular and biological characterization of a murine ligand for CD40 , 1992, Nature.

[14]  S. Ferrone Melanoma, immune surveillance, and immunotherapy. , 1994, The Journal of clinical investigation.

[15]  K P Lee,et al.  Differential T cell costimulatory requirements in CD28-deficient mice. , 1993, Science.

[16]  H. Spits,et al.  CD40 expressed on thymic epithelial cells provides costimulation for proliferation but not for apoptosis of human thymocytes. , 1996, Journal of immunology.

[17]  P. Linsley,et al.  Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7. , 1993, Journal of immunology.

[18]  W. Fanslow,et al.  CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40 , 1993, The Journal of experimental medicine.

[19]  H. Stein,et al.  Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease , 1992, Cell.

[20]  H. Ploegh,et al.  Generation, translocation, and presentation of MHC class I-restricted peptides. , 1995, Annual review of biochemistry.

[21]  J. Simon,et al.  Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis. , 1999, Cancer research.

[22]  G. Freeman,et al.  Isolated human follicular dendritic cells display a unique antigenic phenotype , 1989, The Journal of experimental medicine.

[23]  J. Banchereau,et al.  Functions of CD40 on B cells, dendritic cells and other cells. , 1997, Current opinion in immunology.

[24]  V. Cerundolo,et al.  An Expanded Peripheral T Cell Population to a Cytotoxic T Lymphocyte (Ctl)-Defined, Melanocyte-Specific Antigen in Metastatic Melanoma Patients Impacts on Generation of Peptide-Specific Ctls but Does Not Overcome Tumor Escape from Immune Surveillance in Metastatic Lesions , 1999, The Journal of experimental medicine.

[25]  H. Engelmann,et al.  A novel function of CD40: induction of cell death in transformed cells , 1996, The Journal of experimental medicine.

[26]  M. Jenkins,et al.  Monocytes provide a novel costimulatory signal to T cells that is not mediated by the CD28/B7 interaction. , 1994, Journal of immunology.

[27]  Tumor antigens. , 1981, The New England journal of medicine.

[28]  P. Kiener,et al.  Expression of functional CD40 by vascular endothelial cells , 1995, The Journal of experimental medicine.

[29]  R. Flavell,et al.  CD40 and CD154 in cell-mediated immunity. , 1998, Annual review of immunology.

[30]  L. Davis,et al.  The CD40 ligand expressed by human B cells costimulates B cell responses. , 1995, Journal of immunology.

[31]  H. Spits,et al.  A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction , 1997, The Journal of experimental medicine.

[32]  E. Danen,et al.  Establishment and characterization of an uveal‐melanoma cell line , 1995, International journal of cancer.

[33]  S. Rosenberg,et al.  Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. , 1994, Journal of the National Cancer Institute.

[34]  L. Lanier,et al.  CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes , 1992, The Journal of experimental medicine.

[35]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[36]  K. Kishi,et al.  Induction of human IgE synthesis in B cells by mast cells and basophils , 1993, Nature.

[37]  R. Noelle,et al.  The role of CD40 in the regulation of humoral and cell-mediated immunity. , 1994, Immunology today.

[38]  G. Freeman,et al.  Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27. , 1994, Journal of immunology.

[39]  T. Boon,et al.  Tumor antigens recognized by T lymphocytes , 1997, International journal of clinical & laboratory research.

[40]  B. Seed,et al.  The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. , 1991, Journal of immunology.

[41]  R. V. van Lier,et al.  A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death. , 1996, Journal of immunology.

[42]  D. Gray,et al.  CD40 ligand-transduced co-stimulation of T cells in the development of helper function , 1995, Nature.

[43]  H. Spits,et al.  CD40 is functionally expressed on human thymic epithelial cells. , 1992, Journal of immunology.

[44]  Terry Farrah,et al.  The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.

[45]  T. Kipps,et al.  Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal , 1993, The Journal of experimental medicine.

[46]  S. Paulie,et al.  Stimulation of CD40 in human bladder carcinoma cells inhibits anti‐FAS/APO‐1 (CD95)‐induced apoptosis , 1998, International journal of cancer.

[47]  P. Borrow,et al.  CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response , 1996, The Journal of experimental medicine.

[48]  Alejandro Aruffo,et al.  CD40 is functionally expressed on human keratinocytes , 1996, European journal of immunology.

[49]  L. Lanier,et al.  CD40 preferentially costimulates activation of CD4+ T lymphocytes. , 1994, Journal of immunology.

[50]  P. Linsley,et al.  Costimulation of T cells for tumor immunity. , 1993, Immunology today.

[51]  D. Choy,et al.  Nasopharyngeal carcinoma and lymphoinfiltration. , 1991, Oncology.

[52]  Richard A. Flavell,et al.  Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.

[53]  R. Looney,et al.  CD40 expression by human fibroblasts. , 1995, Clinical immunology and immunopathology.

[54]  R. Callard,et al.  CD40 ligand and its role in X-linked hyper-IgM syndrome. , 1993, Immunology today.

[55]  L. Lanier,et al.  Multicolor immunofluorescence and flow cytometry , 1991 .

[56]  R. Noelle,et al.  CD40 and its ligand in host defense. , 1996, Immunity.

[57]  E. Clark,et al.  CD40: a cytokine receptor in search of a ligand. , 1990, Tissue antigens.